KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia completes recruitment to Cantrixil Phase 1 trial, page-65

  1. 1,163 Posts.
    lightbulb Created with Sketch. 860
    I Agree,
    Auditors report dated 29 August 2017
    "Material Uncertainty Related to Going Concern We draw attention to Note 2 in the financial statements, which indicates that the Group incurred a net loss of $10,670,377 and net operating cash outflows of $11,434,698 during the year ended 30 June 2017. As stated in Note 2, these events or conditions, along with other matters as set forth in Note 2, indicate that a material uncertainty exists that may cast doubt on the Group’s ability to continue as a going concern. Our opinion is not modified in respect of this matter"

    Regards.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.